
By EMILY BAUMGAERTNER from NYT Health https://ift.tt/2QEw4Mc

Children with fetal alcohol syndrome face a range of lifelong problems including birth defects, growth problems, developmental delays, intellectual disability and behavioral disorders, all of which can require costly care.
The therapy targets the genetic flaw that causes sickle cell. In a small group of patients, researchers said the therapy appears safe and effective enough to keep moving forward into larger trials.
A new report confirms that eczema risk is common among children, that risk starts to drop off by young adulthood and middle age, but rises again when people reach their 70s.
Between 60 and 80 percent of people admit they avoid telling their doctor details that could be relevant to their well-being.